Manufacturer record
Relief Biotech Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Relief Biotech Pvt. Ltd (Delhi) were declared Not of Standard Quality between March 2023 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: RT-251154, Telmisartan Tablets IP 40mg (exp Oct 2027). SDTL, Punjab (state lab) found it not of standard quality: 1. Description 2. Dissolution (7Units Foumd to be less than 60% against I.P Limit of max. Two Units to be less than 60% against labeled. Listed in the June 2026 alert.
Records by type
11 records linked to Relief Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 40mg | Batch RT-251154Mfg Nov 2025 · Exp Oct 2027 | 1. Description 2. Dissolution (7Units Foumd to be less than 60% against I.P Limit of max. Two Units to be less than 60% against labeled claim also 7units found to be less than 50% against I.P Limit of No Unit to be less than 50% against Labeled claim.)Dissolution | SDTL, PunjabState lab | Jun 2026 |
| Norfloxacin Tablets IP 400 mg | Batch RT-250413Mfg Apr 2025 · Exp Mar 2027 | ContentOther | DTL, Madurai-19State lab | May 2026 |
| Atorvastatin Tablets IP 10mg | Batch RT - 250622Mfg Jun 2025 · Exp May 2027 | DissolutionDissolution | DTL, Chennai-06State lab | May 2026 |
| Amlodipine Tablets IP 5mg | Batch RT-251061Mfg Oct 2025 · Exp Sep 2027 | ContentOther | DTL,Chennai-06State lab | Feb 2026 |
| Atorvastatin Tablets IP 10mg | Batch RT-250560Mfg May 2025 · Exp Apr 2027 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Amlodipine Tablets IP 5mg | Batch RT-2505104Mfg May 2025 · Exp Apr 2027 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Telmisartan Tablets IP 40mg | Batch RT-250582Mfg May 2025 · Exp Apr 2027 | DescriptionDescription | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Ramipril Tablets I.P. 2.5 mg | Batch RT-231084Mfg Oct 2023 · Exp Sep 2025 | Assay of RamiprilAssay | RDTL GuwahatiCDSCO lab | Sep 2024 |
| Vitamin B Complex Tablets | Batch RT-220598Mfg May 2022 · Exp Oct 2023 | Description and Assay of Thiamine HydrochlorideAssay | CDL KolkataCDSCO lab | Mar 2023 |
| Calcium & Vitamin D3 Tablets I. P. | Batch RT-221004Mfg Oct 2022 · Exp Mar 2024 | Identification and Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Mar 2023 |
| Calcium & Vitamin D3 Tablets I.P. | Batch RT-221008Mfg Oct 2022 · Exp Mar 2024 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Mar 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.